Reneo Pharmaceuticals, Inc. (RPHM)
NASDAQ: RPHM · IEX Real-Time Price · USD
1.750
+0.090 (5.42%)
At close: May 17, 2024, 4:00 PM
1.700
-0.050 (-2.86%)
After-hours: May 17, 2024, 7:30 PM EDT

Reneo Pharmaceuticals Statistics

Total Valuation

RPHM has a market cap or net worth of $58.49 million. The enterprise value is -$23.44 million.

Market Cap 58.49M
Enterprise Value -23.44M

Important Dates

The last earnings date was Tuesday, May 7, 2024, before market open.

Earnings Date May 7, 2024
Ex-Dividend Date n/a

Share Statistics

RPHM has 33.42 million shares outstanding. The number of shares has increased by 33.49% in one year.

Shares Outstanding 33.42M
Shares Change (YoY) +33.49%
Shares Change (QoQ) -0.38%
Owned by Insiders (%) 3.08%
Owned by Institutions (%) 88.26%
Float 8.97M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.72
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 29.83, with a Debt / Equity ratio of 0.01.

Current Ratio 29.83
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -67.80% and return on invested capital (ROIC) is -93.12%.

Return on Equity (ROE) -67.80%
Return on Assets (ROA) -60.10%
Return on Capital (ROIC) -93.12%
Revenue Per Employee n/a
Profits Per Employee -$8.84M
Employee Count 8
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -77.71% in the last 52 weeks. The beta is 0.23, so RPHM's price volatility has been lower than the market average.

Beta (1Y) 0.23
52-Week Price Change -77.71%
50-Day Moving Average 1.69
200-Day Moving Average 4.14
Relative Strength Index (RSI) 54.03
Average Volume (30 Days) 278,346

Short Selling Information

The latest short interest is 3.07 million, so 9.19% of the outstanding shares have been sold short.

Short Interest 3.07M
Short Previous Month 2.94M
Short % of Shares Out 9.19%
Short % of Float 34.23%
Short Ratio (days to cover) 28.20

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -76.50M
Pretax Income -70.71M
Net Income -70.71M
EBITDA -70.26M
EBIT -70.71M
Earnings Per Share (EPS) -$2.18
Full Income Statement

Balance Sheet

The company has $82.84 million in cash and $907,000 in debt, giving a net cash position of $81.93 million or $2.45 per share.

Cash & Cash Equivalents 82.84M
Total Debt 907,000
Net Cash 81.93M
Net Cash Per Share $2.45
Equity / Book Value 81.24M
Book Value Per Share 2.43
Working Capital 81.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.65 million and capital expenditures -$49,000, giving a free cash flow of -$75.70 million.

Operating Cash Flow -75.65M
Capital Expenditures -49,000
Free Cash Flow -75.70M
FCF Per Share -$2.27
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RPHM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -33.49%
Shareholder Yield -33.49%
Earnings Yield -120.89%
FCF Yield -129.42%

Analyst Forecast

The average price target for RPHM is $11.46, which is 554.86% higher than the current price. The consensus rating is "Buy".

Price Target $11.46
Price Target Difference 554.86%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2